Glaxo wins appeals court ruling on Wellbutrin patent

LONDON (CBS.MW) -- GlaxoSmithKline
GSK, +0.21%GSK, -0.44%
on Monday won a court victory, as a U.S. Federal Appeals Court said a lower court should review whether Andrx
adrx
infringed upon a patent involving Glaxo's antidepressant Wellbutrin SR. Impax Laboratories
IPXL, -2.00%
and Eon Labs
EON, +1.19%
both have previously won court victories allowing generics of the same drug.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.